Pro Research: Wall Street dives into Regeneron’s robust prospects By Investing.com
[ad_1] © Reuters. Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy...
US FDA approves Regeneron’s ultra-rare blood disease drug By Reuters
[ad_1] © Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S....
US FDA approves higher dose of Regeneron’s eye disease drug Eylea By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....
US FDA declines to approve Regeneron’s higher-dose Eylea, shares tumble By Reuters
[ad_1] © Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S....